| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.96B | 45.08B | 43.79B | 40.21B | 37.73B | 33.92B |
| Gross Profit | 29.43B | 28.15B | 27.49B | 25.49B | 23.21B | 20.48B |
| EBITDA | 3.73B | 3.50B | 3.65B | 2.88B | 1.57B | 358.59M |
| Net Income | 1.15B | 1.73B | 968.52M | 752.04M | -403.19M | 942.53M |
Balance Sheet | ||||||
| Total Assets | 30.47B | 31.12B | 29.20B | 28.73B | 28.73B | 34.12B |
| Cash, Cash Equivalents and Short-Term Investments | 2.78B | 2.38B | 2.26B | 2.29B | 2.37B | 7.91B |
| Total Debt | 8.84B | 7.87B | 8.26B | 8.78B | 9.71B | 14.38B |
| Total Liabilities | 16.53B | 15.89B | 15.56B | 15.87B | 16.86B | 21.60B |
| Stockholders Equity | 13.93B | 15.23B | 13.65B | 12.86B | 11.87B | 12.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.04B | 889.33M | 971.51M | -539.58M | 892.84M |
| Operating Cash Flow | 0.00 | 2.95B | 3.10B | 2.88B | 1.35B | 2.46B |
| Investing Cash Flow | 0.00 | -2.04B | -2.27B | -1.95B | -2.08B | -1.49B |
| Financing Cash Flow | 0.00 | -818.77M | -919.50M | -1.05B | -4.81B | -1.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥139.50B | 119.46 | ― | 1.71% | 7.39% | -19.24% | |
70 Outperform | ¥119.95B | 20.09 | ― | 0.70% | 6.85% | 45.60% | |
65 Neutral | ¥250.36B | 33.85 | 9.66% | 0.55% | 15.12% | 18.16% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥656.23B | 35.05 | 9.53% | 0.55% | 12.02% | 20.18% | |
61 Neutral | ¥204.41B | 37.97 | ― | 0.69% | 10.09% | 22.64% | |
60 Neutral | ¥55.20B | 15.70 | ― | 0.56% | 2.94% | 78.37% |